Literature DB >> 21527393

Intellectual and behavioral functioning in a South african cohort of boys with duchenne muscular dystrophy.

Kirsten A M Donald1, Hlengani Mathema, Kevin G F Thomas, Jo M Wilmshurst.   

Abstract

The authors describe the neurocognitive and behavioral phenotype of 16 South African children (ages 4-16 years) with Duchenne muscular dystrophy, compared with 13 controls. The preschool group performed significantly worse than the controls in measures of general developmental performance. The school-age group showed no significant differences in general intellectual abilities. However, our data identified that boys with Duchenne muscular dystrophy experience mild cognitive dysfunction across multiple domains, including visual memory, and verbal and nonverbal executive functioning. Parental reports of 11 boys with the disorder revealed high rates of general behavioral problems (54.5%). The cognitive profile of boys with Duchenne muscular dystrophy in South Africa is similar to that described elsewhere in the world. Behavioral problems in our cohort were higher than previously reported. This may be partially explained by the poor socioeconomic background of the majority of the cohort.

Entities:  

Mesh:

Year:  2011        PMID: 21527393     DOI: 10.1177/0883073811399149

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

Review 1.  Dystrophin induced cognitive impairment: mechanisms, models and therapeutic strategies.

Authors:  Akshay Anand; Rahul Tyagi; Manju Mohanty; Manoj Goyal; K Ranil D De Silva; Nalaka Wijekoon
Journal:  Ann Neurosci       Date:  2015-04

2.  Prednisone and Deflazacort in Duchenne Muscular Dystrophy: Do They Play a Different Role in Child Behavior and Perceived Quality of Life?

Authors:  Susan Sienko; Cathleen Buckon; Eileen Fowler; Anita Bagley; Loretta Staudt; Mitell Sison-Williamson; Kathy Zebracki; Craig M McDonald; Michael Sussman
Journal:  PLoS Curr       Date:  2016-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.